Octean Pharma ApS: Financial statements 2019
CVR: 38023667
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 1,126,618 and a net result of DKK 50,720 compared with DKK 97,173 the year before. That is an increase of 33.4% compared with the year before. The profit margin was 4.5%. Equity in the 2019 report amounted to DKK 36,116. The solvency ratio was 6%.
- Revenue
- DKK 1,126,618
- Gross Profit
- DKK 750,666
- Profit/Loss
- DKK 50,720
- Equity
- DKK 36,116
- Total Assets
- DKK 604,068
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 1.1 mio. | 751 t. | 51 t. | 36 t. | - |
| 2018 | 844 t. | 584 t. | 97 t. | -15 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Octean Pharma ApS has published its annual report for 2018. Revenue came to DKK 844,379, and the net result was DKK 97,173.
As of January 7, 2019, Lotte Johannesson is registered as director of Octean Pharma ApS.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.